胆管细胞损伤型药物性肝损伤病理与临床生化特征分析

叶立红; 王翀奎; 邵晨; 张海丛; 刘志权; 王泰龄

doi:10.3969/j.issn.1001-5256.2020.05.022

胆管细胞损伤型药物性肝损伤病理与临床生化特征分析

DOI: 10.3969/j.issn.1001-5256.2020.05.022

1. 石家庄市第五医院病理科
2. 河北中医学院实验中心
3. 中日友好医院病理科

基金项目:

中国肝炎防治基金会-天晴肝病研究基金资助课题（TQGB20200047）；

详细信息

中图分类号: R575
计量
- 文章访问数: 857
- HTML全文浏览量: 17
- PDF下载量: 155
- 被引次数: 0
出版历程
- 出版日期: 2020-05-20

Clinical and biochemical features of bile duct injury type of drug-induced liver injury

Department of Pathology, Shijiazhuang Fifth Hospital, Shijiazhuang 050021, China

Research funding:

摘要

摘要:
目的分析胆管细胞损伤型药物性肝损伤（DILI）各病理亚型的病理与临床生化学特点,进而验证DILI病理分类的划分价值及意义。方法采用回顾性研究方法,收集2006年1月-2016年1月石家庄市第五医院及2003年10月-2014年6月中日友好医院胆管细胞损伤型DILI患者112例。依据不同病理亚型分为混合性肝炎组（混合组）40例,淤胆性肝炎组（淤胆组）40例,单纯性淤胆组（单纯组）32例。分析各亚型用药种类、病程、R值、肝生化学各指标高峰值及变化趋势、以及肝生化各指标达峰时间及恢复时间等特点。计量资料多组间比较采用独立样本Kruskal-WallisH非参数检验,两组间比较采用Mann-WhitneyU检验。计数资料组间比较采用χ2检验。结果引起DILI的药物分类中,中药及西药在胆管细胞损伤型DILI约各占一半。中药主要包括治疗骨关节病、椎间盘膨出、脱发、排石利胆、壮阳、皮肤病等药物,其中淤胆组中药所占比例最高,高达65%（26例）,混合组为40%（16例）,单纯组为40. 6%（13例）;引起DILI前两位的西药分别为抗生素、解热镇痛药。混合组、淤胆组、单纯组ALT...
- 药物性肝损伤 /
- 胆管细胞损伤 /
- 病理状态,体征和症状
Abstract:
Objective To investigate the pathological and biochemical features of each pathological subtype of bile duct injury type of drug-induced liver injury(DILI), and to verify the value and significance of pathological classification of DILI.Methods A retrospective analysis was performed for the clinical data of 112 patients with bile duct injury type of DILI who were admitted to Shijiazhuang Fifth Hospital from January 2006 to January 2016 and China-Japan Friendship Hospital from October 2003 to June 2014. According to the pathological subtype, the patients were divided into mixed hepatitis group with 40 patients, cholestatic hepatitis group with 40 patients, and simple cholestasis group with 32 patients, and the three groups were compared in terms of types of drugs used, course of disease, R value, and peak values,changing trend, time to peak, and recovery time of liver biochemical indices. The independent-samples Kruskal-WallisHtest was used for comparison of continuous data between multiple groups, and the Mann-WhitneyUtest was used for further comparison between two groups; the chi-square test was used for comparison of categorical data between groups.Results Among the drugs inducing DILI, traditional Chinese medicine and Western medicine each accounted for half of the cases of bile duct injury type of DILI. Traditional Chinese medicine mainly included the drugs for osteoarthropathy, intervertebral disc bulge, alopecia, calculus-removing and cholagogic treatment,Yang-tonifying therapy, and skin diseases; 26 patients(65%) in the cholestatic hepatitis group had DILI caused by traditional Chinese medicine, while 16 patients(40%) in the mixed hepatitis group and 13(40.6%) in the simple cholestasis group had such DILI. Antibiotics and antipyretic and analgesic drugs were the most common Western medicines for DILI. The mixed hepatitis group had the highest peak values of ALT and AST and R value, followed by the cholestatic hepatitis group and the simple hepatitis group （χ2 =54. 77, 44. 21, and5195, allP< 0. 001), and there were no significant differences in the peak values of the other liver biochemical parameters between the three groups(allP> 0. 05). In the mixed hepatitis group and the cholestatic hepatitis group, the time to peak of TBil was longer than that of ALT. There were no significant differences in course of disease, time to peak of liver biochemical parameters, and recovery time between the three groups(allP> 0. 05).Conclusion Each subtype of bile duct injury type of DILI has unique clinical and biochemical features,and an understanding of such features may help to accurately judge clinical typing, pathological changes of targets, and degree of injury.
- drug-induced liver injury /
- bile duct cell injury /
- pathological conditions,signs and symptoms

HTML全文

参考文献(10)

[1] BENICHOU C. Criteria of drug-induced liver disorders. Report of an international consensus meeting[J]. J Hepatol,1990, 11(2):272-276.

[2] Drug-induced liver injury group of the liver Department of the Chinese Medical Association. Interpretation of CSH clinical guideline:The diagnosis and management of drug-induced liver injury[M]. Shanghai:Shanghai Science and Technology Press, 2015:21-22.(in Chinese）中华医学会肝脏病学分会药物性肝损伤组．物性肝损伤诊治指南解读[M]．上海：上海科学技术出版社，2015:21-22.

[3] WANG TL, ZHAO XY, SHAO C, et al. A proposed pathologic sub-classification of drug-induced liver injury[J]. Hepatol Int, 2019, 13:339-351.

[4] SHEN T, HUANG X, WANG YY, et al. Current status of epidemiological studies on drug-induced liver injury in China[J]. J Clin Hepatol, 2018, 34(6):1152-1155.(in Chinese）沈弢，黄昕，王誉雅，等．我国药物性肝损伤流行病学研究现状[J]．临床肝胆病杂志，2018, 34(6):1152-1155.

[5] YANG H, WANG XQ, BAI YQ. Clinical analysis of 115 patients with drug-induced liver disease[J]. J Medical Forum, 2010,31(8):70-74.(in Chinese）杨惠，王修齐，白阳秋．药物性肝损伤115例临床分析[J]．医药论坛杂志，2010, 31(8):70-74.

[6] HU Q, LIU W, SHAO H. Research progress of pharmacotherapy drug-induced liver injury[J]. Chin J Clin Pharmacol Ther, 2016, 21(2):231-236.(in Chinese）胡琴，刘维，邵宏．药物性肝损伤的药物治疗研究进展[J]．中国临床药理学与治疗学，2016, 21(2):231-236.

[7] HE WP, XU B, WANG HF, et al. Correlation between clinical classification and histopathology in drug-induced liver injury[J]. Chin Hepatol, 2010, 15(4):241-243.(in Chinese）何卫平，许彪，王慧芬，等．药物性肝病临床分型和病理相关性分析[J]．肝脏，2010, 15(4):241-243.

[8] YU YC, HE CL. The prognosis of hepatic injury and Live tissue repair[J]. Chin Hepatol, 2010, 15(6):460-464.(in Chinese）于乐成，何长伦．肝损伤转归与肝组织修复[J]．肝脏，2010,15(6):460-464.

[9] MEHENDALE HM. Tissue repair:An important determinant of final outcome of toxicant-induced injury[J]. Toxicol Pathol,2005, 33(1):41-51.

[10] SUZAKI Y, KATAGIRL H, WANG T, et al. Ductular reaction in the liver regenerantin process with local inflammation after physical partial hepatectomy[J]. Lab Invest, 2016, 96(11):1211-1222.

施引文献

资源附件(0)

访问统计